文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

16个国家重症监护病房中急性呼吸窘迫综合征风险患者的流行病学特征、通气实践与临床结局(PRoVENT):一项国际多中心前瞻性研究

Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study.
PubMed 文献 · Lancet Respir Med · 2016-10-04
一句话结论ICU机械通气患者中约30%存在ARDS风险(LIPS≥4),其肺部并发症更多、住院/ICU/90天死亡率均高于无风险者,而潮气量设置两组无差异。

PRoVENT为16国119个ICU的国际多中心前瞻性研究,纳入2014年1月至2015年1月间1周内所有≥18岁机械通气患者,用肺损伤预测评分(LIPS)分层,LIPS≥4定义为ARDS风险。935例符合标准者中282例(30%,95%CI 27-33)存在ARDS风险,相当于每ICU床位每周0.14例。风险组与无风险组潮气量相似(中位7.6 vs 7.9 mL/kg PBW,p=0.346),风险组PEEP更高(中位6.0 vs 5.0 cm H2O,p<0.0001)。风险组ARDS发生率更高(19/260 [7%] vs 17/556 [3%],p=0.004),住院死亡率(86/543 [16%] vs 74/232 [32%],p<0.0001)、ICU死亡率(62/533 [12%] vs 66/227 [29%],p<0.0001)和90天死亡率(109/653 [17%] vs 88/282 [31%],p<0.0001)均更高。作者认为无ARDS患者通气管理存在改善空间,ARDS预测仍需进一步改进。

要点

  • ICU机械通气患者中约30%(95%CI 27-33)存在ARDS风险(LIPS≥4),相当于每ICU床位每周0.14例。
  • ARDS风险组住院死亡率32% vs 无风险组16%(p<0.0001),ICU死亡率29% vs 12%(p<0.0001),90天死亡率31% vs 17%(p<0.0001)。
  • ARDS风险组PEEP中位6.0 cm H2O vs 无风险组5.0 cm H2O(p<0.0001),但潮气量两组相似(7.6 vs 7.9 mL/kg PBW,p=0.346)。
  • ARDS风险组后续ARDS发生率7%(19/260)vs 无风险组3%(17/556)(p=0.004)。
  • 作者认为无ARDS患者的通气管理存在改善空间,ARDS预测方法仍需进一步改进。

适用人群与场景

  • 2014年1月至2015年1月间1周内,16国119个ICU中所有≥18岁接受机械通气的患者。

诊断标准与关键阈值

  • 采用肺损伤预测评分(LIPS)分层,评分≥4分定义为存在ARDS风险。

研究设计与关键结果

  • 国际多中心前瞻性研究,16国119个ICU,筛查3023例,935例符合纳入标准,其中282例存在ARDS风险(30%,95%CI 27-33)。
  • 潮气量:风险组中位7.6 mL/kg PBW(IQR 6.7-9.1)vs 无风险组7.9 mL/kg PBW(IQR 6.8-9.1),p=0.346。
  • PEEP:风险组中位6.0 cm H2O(IQR 5.0-8.0)vs 无风险组5.0 cm H2O(IQR 5.0-7.0),p<0.0001。
  • ARDS发生率:风险组19/260(7%)vs 无风险组17/556(3%),p=0.004。
  • 住院死亡率:风险组86/543(16%)vs 无风险组74/232(32%),p<0.0001。
  • ICU死亡率:风险组62/533(12%)vs 无风险组66/227(29%),p<0.0001。
  • 90天死亡率:风险组109/653(17%)vs 无风险组88/282(31%),p<0.0001。
  • 潮气量在是否发生ARDS的患者间无差异(风险组p=0.471,无风险组p=0.323)。

证据类型、等级与局限

  • 证据类型:国际多中心前瞻性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为无ARDS患者的通气管理存在改善空间。
  • 作者认为ARDS预测方法仍需进一步改进。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Scant information exists about the epidemiological characteristics and outcome of patients in the intensive care unit (ICU) at risk of acute respiratory distress syndrome (ARDS) and how ventilation is managed in these individuals. We aimed to establish the epidemiological characteristics of patients at risk of ARDS, describe ventilation management in this population, and assess outcomes compared with people at no risk of ARDS.

METHODS: PRoVENT (PRactice of VENTilation in critically ill patients without ARDS at onset of ventilation) is an international, multicentre, prospective study undertaken at 119 ICUs in 16 countries worldwide. All patients aged 18 years or older who were receiving mechanical ventilation in participating ICUs during a 1-week period between January, 2014, and January, 2015, were enrolled into the study. The Lung Injury Prediction Score (LIPS) was used to stratify risk of ARDS, with a score of 4 or higher defining those at risk of ARDS. The primary outcome was the proportion of patients at risk of ARDS. Secondary outcomes included ventilatory management (including tidal volume [VT] expressed as mL/kg predicted bodyweight [PBW], and positive end-expiratory pressure [PEEP] expressed as cm H2O), development of pulmonary complications, and clinical outcomes. The PRoVENT study is registered at ClinicalTrials.gov, NCT01868321. The study has been completed.

FINDINGS: Of 3023 patients screened for the study, 935 individuals fulfilled the inclusion criteria. Of these critically ill patients, 282 were at risk of ARDS (30%, 95% CI 27-33), representing 0·14 cases per ICU bed over a 1-week period. VT was similar for patients at risk and not at risk of ARDS (median 7·6 mL/kg PBW [IQR 6·7-9·1] vs 7·9 mL/kg PBW [6·8-9·1]; p=0·346). PEEP was higher in patients at risk of ARDS compared with those not at risk (median 6·0 cm H2O [IQR 5·0-8·0] vs 5·0 cm H2O [5·0-7·0]; p<0·0001). The prevalence of ARDS in patients at risk of ARDS was higher than in individuals not at risk of ARDS (19/260 [7%] vs 17/556 [3%]; p=0·004). Compared with individuals not at risk of ARDS, patients at risk of ARDS had higher in-hospital mortality (86/543 [16%] vs 74/232 [32%]; p<0·0001), ICU mortality (62/533 [12%] vs 66/227 [29%]; p<0·0001), and 90-day mortality (109/653 [17%] vs 88/282 [31%]; p<0·0001). VT did not differ between patients who did and did not develop ARDS (p=0·471 for those at risk of ARDS; p=0·323 for those not at risk).

INTERPRETATION: Around a third of patients receiving mechanical ventilation in the ICU were at risk of ARDS. Pulmonary complications occur frequently in patients at risk of ARDS and their clinical outcome is worse compared with those not at risk of ARDS. There is potential for improvement in the management of patients without ARDS. Further refinements are needed for prediction of ARDS.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Neto AS, Barbas CSV, Simonis FD, et al. Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study. Lancet Respir Med. 2016. PMID: 27717861. doi:10.1016/S2213-2600(16)30305-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。